Coherus Biosciences | CHRS - Deudores Comerciales





Deudores Comerciales Cambio Fecha
AbbVie USD 12.48B 110M 2026-03
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
ALKERMES USD 456.48M 48.85M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.14B 432M 2026-03
Baxter International USD 1.86B 158M 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Fujifilm JPY 887.02B 64.37B 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Merck USD 11.78B 345M 2025-12
Myriad Genetics USD 115.3M 2.7M 2025-12
Pacira USD 125.64M 1.57M 2026-03
Perrigo USD 697.1M 84.3M 2026-03
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 219.92M 38.3M 2026-03
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Teva Pharmaceutical Industries USD 3.49B 100M 2026-06
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xencor USD 12M 17.3M 2026-03
Zoetis USD 1.51B 84M 2026-03